Table 2 Treatment plan recommendations pre- and post-70-GS results, according to clinical and genomic risk result category
From: MammaPrint guides treatment decisions in breast Cancer: results of the IMPACt trial
Treatment Decisions Pre- to Post-70-GS | ||||||
|---|---|---|---|---|---|---|
Clinical, Genomic Risk Summary | Chemo to Chemo | Chemo to No Chemo | No Chemo to Chemo | No Chemo to no Chemo | Total | p-value |
C-low, G-low | 4 (2.5%) | 23 (14.4%) | 0 (0.0%) | 133 (83.1%) | 160 | p < 0.0001 |
C-high, G-low | 14 (21.9%) | 21 (32.8%) | 1(1.6%) | 28 (43.8%) | 64 | |
C-low, G-high | 24 (35.8%) | 0 (0.0%) | 26 (40.6%) | 17 (26.6%) | 67 | |
C-high, G-high | 47 (70.1%) | 0 (0.0%) | 15 (23.4%) | 5 (7.8%) | 67 | |
Total | 89 (24.9%) | 44 (12.3%) | 42 (11.7%) | 183 (51.1%) | 358 | |